Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)

NCT02802592 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02802592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02802592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
Lead sponsor
Johns Hopkins University
Phase
Phase 1/2
Overall status
Terminated
Start date
May 31, 2015
Completion date
February 27, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery-cabg, cardiac valve replacement